BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 26318718)

  • 1. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells.
    Chen VC; Ye J; Shukla P; Hua G; Chen D; Lin Z; Liu JC; Chai J; Gold J; Wu J; Hsu D; Couture LA
    Stem Cell Res; 2015 Sep; 15(2):365-75. PubMed ID: 26318718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale production of human pluripotent stem cell derived cardiomyocytes.
    Kempf H; Andree B; Zweigerdt R
    Adv Drug Deliv Rev; 2016 Jan; 96():18-30. PubMed ID: 26658242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The suspension culture of undifferentiated human pluripotent stem cells using spinner flasks.
    Chen VC; Couture LA
    Methods Mol Biol; 2015; 1283():13-21. PubMed ID: 25537838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture.
    Halloin C; Schwanke K; Löbel W; Franke A; Szepes M; Biswanath S; Wunderlich S; Merkert S; Weber N; Osten F; de la Roche J; Polten F; Christoph Wollert K; Kraft T; Fischer M; Martin U; Gruh I; Kempf H; Zweigerdt R
    Stem Cell Reports; 2019 Aug; 13(2):366-379. PubMed ID: 31353227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol.
    Fonoudi H; Ansari H; Abbasalizadeh S; Blue GM; Aghdami N; Winlaw DS; Harvey RP; Bosman A; Baharvand H
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27500408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture.
    Kempf H; Olmer R; Kropp C; Rückert M; Jara-Avaca M; Robles-Diaz D; Franke A; Elliott DA; Wojciechowski D; Fischer M; Roa Lara A; Kensah G; Gruh I; Haverich A; Martin U; Zweigerdt R
    Stem Cell Reports; 2014 Dec; 3(6):1132-46. PubMed ID: 25454631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
    Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
    Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
    Ting S; Chen A; Reuveny S; Oh S
    Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac differentiation of human pluripotent stem cells in scalable suspension culture.
    Kempf H; Kropp C; Olmer R; Martin U; Zweigerdt R
    Nat Protoc; 2015 Sep; 10(9):1345-61. PubMed ID: 26270394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
    Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
    Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meticulous optimization of cardiomyocyte yields in a 3-stage continuous integrated agitation bioprocess.
    Ting S; Lam A; Tong G; Chen A; Wei H; Wu J; Lam YN; Reuveny S; Oh S
    Stem Cell Res; 2018 Aug; 31():161-173. PubMed ID: 30098478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a Cost-Effective and Scalable Production of Human Hepatic Competent Endoderm from Size-Controlled Pluripotent Stem Cell Aggregates.
    Farzaneh Z; Najarasl M; Abbasalizadeh S; Vosough M; Baharvand H
    Stem Cells Dev; 2018 Feb; 27(4):262-274. PubMed ID: 29298619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Cardiomyocytes from Human Pluripotent Stem Cells by Bioreactor Technologies.
    Halloin C; Coffee M; Manstein F; Zweigerdt R
    Methods Mol Biol; 2019; 1994():55-70. PubMed ID: 31124104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating cell state to enhance suspension expansion of human pluripotent stem cells.
    Lipsitz YY; Woodford C; Yin T; Hanna JH; Zandstra PW
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):6369-6374. PubMed ID: 29866848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems.
    Badenes SM; Fernandes TG; Rodrigues CAV; Diogo MM; Cabral JMS
    J Biotechnol; 2016 Sep; 234():71-82. PubMed ID: 27480342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.